As an organization founded with an SBIR NIH/NCI grant to develop a patient-centric, AI-driven Deep Learning Clinical Trial ...

The Trump administration has sent an earthquake through the medical research community. The National Institutes of Health is ...

Researchers from TMC and NIBMG have uncovered key genomic factors contributing to hormone treatment resistance in breast cancer. The study identifies mutations in three genes, DNA repair deficiencies, ...

What's at stake in cancer research as the Trump administration moves to cut "indirect funding" to universities? The immediate past leader of the National Cancer Institute says clinical trials will be ...

Learn how false claims and exaggerated treatment information can harm cancer patients and their support network.

Oncologist Dr. Sarah Cate told Newsweek: "Many women simply don't make time for themselves, since they are working and often ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

The total funding amount awarded to Moffitt last year, $44.7 million, was once again the highest in Florida and nearly double ...